Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, Euro 0.12 par value per share
-
Shares outstanding
-
62,254,300
-
Total 13F shares
-
21,631,638
-
Share change
-
-364,177
-
Total reported value
-
$380,302,000
-
Price per share
-
$17.73
-
Number of holders
-
25
-
Value change
-
-$6,827,491
-
Number of buys
-
7
-
Number of sells
-
13
Institutional Holders of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) as of Q3 2021
As of 30 Sep 2021 Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) had 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,631,638 shares of stock of the company.
Largest 10 holders included FMR LLC, Foresite Capital Management IV, LLC, Bain Capital Life Sciences Investors, LLC, GENERAL ATLANTIC, L.P., VIKING GLOBAL INVESTORS LP, venBio Partners LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Cormorant Asset Management, LP, PICTET ASSET MANAGEMENT SA, and VR Adviser, LLC.
This table shows 25 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.